A two-count declaratory judgment action for non-infringement of
U.S. Patent Nos. 6,916,941 and 7,420,069, which are listed in the
U.S. Food and Drug Administration’s Orange Book for Lexapro, filed
by…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.